Polaryx Therapeutics
PLYX
Polaryx Therapeutics (PLYX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Raymond James | Initiated Coverage | Strong Buy | $6.00 | Aug 13, 2026 |
| LUCID CAPITAL MARKETS | Initiated Coverage | Buy | $7.00 | Jul 27, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Jul 9, 2026 |
| Maxim Group | Initiated Coverage | Buy | $10.00 | Feb 27, 2026 |
Frequently asked questions
What is the latest analyst rating on PLYX?
On Aug 13, 2026, Raymond James initiated coverage of Polaryx Therapeutics at Strong Buy with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.